Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Health Care Cost
84%
Diabetic Retinopathy
62%
Insulin Dependent Diabetes Mellitus
55%
Retinopathy
44%
Diabetes
35%
Systematic Review
25%
Personalized Medicine
25%
Maturity Onset Diabetes of the Young
14%
Quality of Life
12%
Diabetic Foot Ulcer
11%
Finger
8%
Antidiabetic Agent
8%
Hemoglobin A1c
8%
Checklist
6%
Nursing and Health Professions
Diabetic Retinopathy
51%
Cost Effectiveness Analysis
51%
Retinopathy
44%
Health Economics
30%
Systematic Review
25%
Cost Utility Analysis
25%
Continuous Glucose Monitoring
25%
Insulin Dependent Diabetes Mellitus
25%
Prevalence
25%
Economic Evaluation
25%
Practice Guideline
25%
Non Insulin Dependent Diabetes Mellitus
16%
Clinical Outcome
12%
Reimbursement
12%
Diabetes Mellitus
12%
All Cause Mortality
12%
Heart Failure
12%
Checklist
8%
Keyphrases
Personalized Screening
25%
Diabetic Retinopathy
25%
Risk Margin
25%
Screening Strategy
25%
Cost-effectiveness
25%
Sight-threatening Retinopathy
25%
Intermittently Scanned Continuous Glucose Monitoring (isCGM)
25%
Continuous Glucose Monitoring
25%
Decision Model
25%
Type I Diabetes
25%
Type 1 Diabetes Mellitus (T1DM)
25%
Cost-utility
25%
Model Validation
12%
Guideline Algorithm
10%
Annual Screening
10%
Health Economic Evaluation
8%
Uncertainty Analysis
8%
Health Economics
8%
Extracted Data
8%
Dutch Guideline
7%
Carer Perspectives
7%
Closed-loop Devices
6%
Type 2 Diabetes Mellitus (T2DM)
5%
Retinopathy
5%
Diabetic Retinopathy Screening
5%
Screening Interval
5%
Screening Model
5%
Timely Diagnosis
5%
